title: Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.
abstract: BACKGROUND
  Fluid resuscitation is widely practiced in intensive care units for the treatment of sepsis. A comparison of the evidence base of different fluids may inform therapeutic choice.
  
  
  METHODS
  The risks of mortality and morbidity (the need for renal replacement therapies (RRT)) were assessed in patients with severe sepsis. A network meta-analysis compared trials for crystalloids, albumin and hydroxyethyl starch (HES). A literature search of human randomized clinical trials was conducted in databases, the bibliographies of other recent relevant systematic reviews and data reported at recent conferences. Mortality outcomes and RRT data with the longest follow up period were compared. A Bayesian network meta-analysis assessed the risk of mortality and a pair-wise metaanalysis assessed RRT using crystalloids as the reference treatment.
  
  
  RESULTS
  13 studies were identified. A fixed-effects meta-analysis of mortality data in the trials demonstrated an odds-ratio (OR) of 0.90 between crystalloids and albumin, 1.25 between crystalloids and HES and 1.40 between albumin and HES. The probability that albumin is associated with the highest survival was 96.4% followed by crystalloid at 3.6%, with a negligible probability for HES. Sub-group analyses demonstrated the robustness of this result to variations in fluid composition, study source and origin of septic shock. A random-effects pairwise comparison for the risk of RRT provided an OR of 1.52 favoring crystalloid over HES.
  
  
  CONCLUSIONS
  Fluid therapy with albumin was associated with the highest survival benefit. The higher morbidity with HES may affect mortality and requires consideration by prescribers.
authors.affiliation: Plasma Protein Therapeutics Association, Global Access, 147 Old Solomons Island Road Suite #100, Annapolis, MD 21401, USA. afarrugia@pptaglobal.org.
authors.forename: M
authors.initials: M
authors.lastname: Bansal
authors.forename: A
authors.initials: A
authors.lastname: Farrugia
authors.forename: S
authors.initials: S
authors.lastname: Balboni
authors.forename: G
authors.initials: G
authors.lastname: Martin
mesh_terms: D000418:Albumins / Q000008:administration & dosage; D001499:Bayes Theorem; D000077324:Crystalloid Solutions; D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage; D007362:Intensive Care Units; D007552:Isotonic Solutions / Q000008:administration & dosage; D017582:Renal Replacement Therapy / Q000379:methods*; D012306:Risk; D018805:Sepsis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D016019:Survival Analysis
chemical_list: D000418:Albumins; D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions
references.citation: Value Health. 2011 Jun;14(4):417-28
references.pmid: 21669366
references.citation: Open Med. 2009;3(4):e196-209
references.pmid: 21688756
references.citation: Intensive Care Med. 2013 Apr;39(4):558-68
references.pmid: 23407978
references.citation: BMJ. 2005 Oct 15;331(7521):897-900
references.pmid: 16223826
references.citation: Stat Med. 2002 Jun 15;21(11):1601-23
references.pmid: 12111922
references.citation: Vox Sang. 1996;70(4):198-202
references.pmid: 9123923
references.citation: Anesthesiology. 2009 Jul;111(1):187-202
references.pmid: 19512862
references.citation: Crit Care Med. 2007 May;35(5):1244-50
references.pmid: 17414736
references.citation: Int J Technol Assess Health Care. 2006 Summer;22(3):288-94
references.pmid: 16984055
references.citation: BMJ. 2012 Sep 11;345:e5798
references.pmid: 22968722
references.citation: N Engl J Med. 2011 Jun 30;364(26):2483-95
references.pmid: 21615299
references.citation: Transfus Med Rev. 2010 Jan;24(1):53-63
references.pmid: 19962575
references.citation: Clin Pharmacokinet. 2012 Apr 1;51(4):225-36
references.pmid: 22420578
references.citation: BMJ. 2006 Nov 18;333(7577):1044
references.pmid: 17040925
references.citation: Crit Care Med. 2001 Jul;29(7):1303-10
references.pmid: 11445675
references.citation: Syst Rev. 2012 Dec 02;1:61
references.pmid: 23198755
references.citation: Wien Klin Wochenschr. 2004 May 31;116(9-10):305-9
references.pmid: 15237655
references.citation: Crit Care Med. 2011 Feb;39(2):386-91
references.pmid: 21248514
references.citation: Cochrane Database Syst Rev. 2012 Dec 12;12:CD004089
references.pmid: 23235602
references.citation: N Engl J Med. 2008 Jan 10;358(2):125-39
references.pmid: 18184958
references.citation: J Hepatol. 2001 Dec;35(6):726-32
references.pmid: 11738099
references.citation: Eur J Prev Cardiol. 2013 Aug;20(4):658-70
references.pmid: 23529608
references.citation: BMJ. 2001 Jul 7;323(7303):42-6
references.pmid: 11440947
references.citation: Crit Care Med. 1983 Nov;11(11):839-50
references.pmid: 6194934
references.citation: BMJ. 2013 Feb 15;346:f839
references.pmid: 23418281
references.citation: Minerva Anestesiol. 2011 May;77(5):562-3
references.pmid: 21540815
references.citation: Stat Med. 2004 Oct 30;23(20):3105-24
references.pmid: 15449338
references.citation: PLoS Clin Trials. 2006 Sep 15;1(5):e21
references.pmid: 16998584
references.citation: Crit Care Med. 2013 Feb;41(2):580-637
references.pmid: 23353941
references.citation: Intensive Care Med. 2013 May;39(5):811-22
references.pmid: 23430019
references.citation: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007594
references.pmid: 20091640
references.citation: N Engl J Med. 2003 Apr 17;348(16):1546-54
references.pmid: 12700374
references.citation: Br J Haematol. 2005 Feb;128(3):393-400
references.pmid: 15667544
references.citation: Eur J Haematol. 2006 Jul;77(1):83-5
references.pmid: 16608502
references.citation: Crit Care Med. 2003 Mar;31(3):946-55
references.pmid: 12627010
references.citation: Can J Anaesth. 2008 Dec;55(12):819-26
references.pmid: 19050085
references.citation: Crit Care. 2012 May 24;16(3):R94
references.pmid: 22624531
references.citation: N Engl J Med. 2012 Nov 15;367(20):1901-11
references.pmid: 23075127
references.citation: Clin Sci (Lond). 1998 Oct;95(4):459-65
references.pmid: 9748422
references.citation: Crit Care. 2010;14(5):R185
references.pmid: 20950434
references.citation: Crit Care. 2004 Aug;8(4):222-6
references.pmid: 15312201
references.citation: N Engl J Med. 2012 Jul 12;367(2):124-34
references.pmid: 22738085
references.citation: J Clin Pharmacol. 2011 Mar;51(3):292-300
references.pmid: 20501941
references.citation: Hepatogastroenterology. 2009 Nov-Dec;56(96):1622-8
references.pmid: 20214205
references.citation: Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000567
references.pmid: 22696320
references.citation: Clin Infect Dis. 2005 Feb 15;40(4):538-45
references.pmid: 15712076
references.citation: JAMA. 2013 Feb 20;309(7):678-88
references.pmid: 23423413
references.citation: Acta Trop. 2004 Apr;90(2):131-40
references.pmid: 15177139
references.citation: Clin Sci (Lond). 2003 Jan;104(1):17-24
references.pmid: 12519083